Miller School Investigators Host Inherited Neuropathies Consortium in Miami
More than 40 scientists and physicians from North America, Europe and Australia gathered in Miami January 28-30 for the Inherited Neuropathies Consortium (INC) meeting. INC is dedicated to conducting clinical, genetic and basic research in different forms of Charcot-Marie-Tooth disease, a disorder that affects the peripheral nerves. There are currently 17 active recruitment and research sites in North America, Europe and Australia, with additional sites being added.
The meeting was hosted by investigators from the University of Miami Miller School of Medicine, led by Mario A. Saporta, M.D., Ph.D., M.B.A., assistant professor of neurology and human genetics, and Stephan L. Züchner, M.D., Ph.D., professor of neurology and human genetics, Chair of the Dr. John T. Macdonald Foundation Department of Human Genetics and Co-Director of the John P. Hussman Institute for Human Genomics.
The conference’s speakers presented on a variety of topics, ranging from pediatrics to late-onset neuropathies, with the goal of identifying the causes and possible treatments for peripheral neuropathies. The collaborations are made possible through awards by the National Institutes of Health to expand the Rare Diseases Clinical Research Network (RDCRN), which was established in 2003 by the NIH Office of Rare Diseases. The RDCRN is designed to advance medical research on rare diseases by facilitating collaboration, study enrollment and data sharing.
The Miller School of Medicine, a proud founding member of the Consortium, is housing all INC-funded genetic studies, as well as a new patient enrollment center, which is directed by Saporta.
The INC principal investigators who attended the conference were thankful to the local organizing team, and for the support from NIH, Charcot-Marie-Tooth Association, The Genesis Project and the Miller School of Medicine.